Financials MicroPort Scientific Corporation

Equities

853

KYG608371046

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. 01:39:00 03/05/2024 pm IST 5-day change 1st Jan Change
6.65 HKD +0.15% Intraday chart for MicroPort Scientific Corporation +12.71% -21.02%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 1,549 1,915 9,653 6,537 4,793 1,559 1,559 -
Enterprise Value (EV) 1 1,748 2,093 8,947 6,026 4,881 1,975 1,854 1,778
P/E ratio 76.8 x 59.8 x -49.3 x -22 x -10.9 x -4.12 x -7.12 x -9.72 x
Yield 0.38% 0.58% 0.1% 0.15% - 0.23% - -
Capitalization / Revenue 2.31 x 2.41 x 14.9 x 8.39 x 5.7 x 2.08 x 1.32 x 1.12 x
EV / Revenue 2.61 x 2.64 x 13.8 x 7.74 x 5.81 x 2.08 x 1.57 x 1.28 x
EV / EBITDA 18.3 x 23.4 x -92.5 x -28.5 x -13 x -5.14 x -14.9 x -28.4 x
EV / FCF 113 x -29.7 x -70.6 x -12.6 x -8.05 x -2.96 x -6.58 x -6.38 x
FCF Yield 0.89% -3.37% -1.42% -7.95% -12.4% -33.7% -15.2% -15.7%
Price to Book 3.27 x 3.62 x 8.59 x 4.42 x 4.23 x 1.64 x 2.06 x 1.77 x
Nbr of stocks (in thousands) 15,75,536 16,16,587 17,83,923 17,94,276 18,21,352 18,31,722 18,31,722 -
Reference price 2 0.9834 1.185 5.411 3.643 2.631 0.8513 0.8513 0.8513
Announcement Date 27/03/19 30/03/20 30/03/21 30/03/22 30/03/23 28/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 669.5 793.5 648.7 778.6 840.8 950.7 1,184 1,390
EBITDA 1 95.29 89.64 -96.74 -211.1 -374.6 -384.6 -124.4 -62.63
EBIT 1 52.05 28.46 -167.6 -293.6 -507 -516.2 -150.1 -18.5
Operating Margin 7.78% 3.59% -25.83% -37.71% -60.29% -54.29% -12.68% -1.33%
Earnings before Tax (EBT) 1 32.93 63.21 -212.9 -337.3 -581.5 -626.5 -273.9 -262.6
Net income 1 23.91 46.28 -191.3 -276.5 -436.5 -477.6 -209.1 -177.7
Net margin 3.57% 5.83% -29.48% -35.51% -51.91% -50.24% -17.66% -12.79%
EPS 2 0.0128 0.0198 -0.1097 -0.1654 -0.2408 -0.2619 -0.1195 -0.0875
Free Cash Flow 1 15.54 -70.59 -126.7 -479.3 -606.6 -588.5 -282 -278.7
FCF margin 2.32% -8.9% -19.53% -61.55% -72.14% -58.81% -23.82% -20.05%
FCF Conversion (EBITDA) 16.31% - - - - - - -
FCF Conversion (Net income) 64.99% - - - - - - -
Dividend per Share 2 0.003700 0.006840 0.005530 0.005490 - 0.002000 - -
Announcement Date 27/03/19 30/03/20 30/03/21 30/03/22 30/03/23 28/03/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 S1 2023 S1
Net sales 1 405 482.6
EBITDA - -
EBIT 1 -218.6 -164.6
Operating Margin -53.98% -34.11%
Earnings before Tax (EBT) 1 -247.8 -206.2
Net income 1 -198.1 -162.6
Net margin -48.92% -33.7%
EPS - -
Dividend per Share - -
Announcement Date 30/08/22 30/08/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 199 178 - - 88.6 186 295 218
Net Cash position 1 - - 706 511 - - - -
Leverage (Debt/EBITDA) 2.089 x 1.985 x - - -0.2366 x -0.7006 x -2.372 x -3.488 x
Free Cash Flow 1 15.5 -70.6 -127 -479 -607 -589 -282 -279
ROE (net income / shareholders' equity) 5.66% 9.62% -23.2% -21.1% -33.2% -32.9% -29.4% -17%
ROA (Net income/ Total Assets) 2.2% 3.22% -9.41% -8.07% -10.4% -8.19% -4.2% -1.67%
Assets 1 1,089 1,436 2,034 3,425 4,187 4,107 4,979 10,674
Book Value Per Share 2 0.3000 0.3300 0.6300 0.8200 0.6200 0.5200 0.4100 0.4800
Cash Flow per Share 2 0.0500 0.0200 -0.0100 -0.1400 -0.1900 -0.1600 -0.0500 -0.0200
Capex 1 68.6 97 104 248 263 74 168 126
Capex / Sales 10.25% 12.23% 15.96% 31.84% 31.31% 7.4% 14.15% 9.07%
Announcement Date 27/03/19 30/03/20 30/03/21 30/03/22 30/03/23 28/03/24 - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
0.8513 USD
Average target price
1.714 USD
Spread / Average Target
+101.34%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 853 Stock
  4. Financials MicroPort Scientific Corporation